Sionna Therapeutics found strong investor interest in its cystic fibrosis drugs, which could rival blockbuster Vertex ...

Correctors bind to the protein and help it fold into the proper shape. Potentiators open channels of the protein. Vertex’s drugs combine both mechanisms to improve CFTR function at the surface ...

The winners, Nathan Gates, Faith Apostolodes, and Kevin Helm have shared some insights as to what inspired their winning ...

Keep your eye on the ball” is a motto for many athletes—and for astronomers trying to find Earth-threatening space rocks ...

If you are a Gemini Advanced subscriber, you can access Gemini 2.0 Pro through the model-picker menu on both desktop and ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

Vertex' outgoing R&D chief Peter Mueller - who has just announced his retirement - must feel he is leaving the company in fine shape.

DIA, a global multidisciplinary life sciences membership association, will bring together thousands of stakeholders from all ...

Certain drugs and a host of nonpharmacologic therapies are key to treating patients who have nociplastic pain, a relatively ...

It is believed around 1,700 people could be eligible for the treatment, while the NHS estimates around 50 people a year will ...

Google’s Najeeb Jarrar says that brands that prioritise mindful marketing and champion data privacy will be the ones that ...

The Summerlin master-planned community offers more than 75 unique floor plans in 15 neighborhoods throughout eight distinct ...